Gastrointestinal Drugs Market Size and Forecast (2021 – 2031)

Irritable Bowel Syndrome Segment, by Application to Account Largest Share in Gastrointestinal Drugs Market during 2023–2031

According to our new research study on “Gastrointestinal Drugs Market Forecast to 2031 – Global Analysis – by Drug Class, Application, Route of Administration, Distribution Channel, and Geography,” the market was valued at US$ 59.71 billion in 2023 and is projected to reach US$ 106.30 billion by 2031; it is expected to register a CAGR of 7.3% during 2023–2031. The gastrointestinal drugs market growth is attributed to the increasing prevalence gastrointestinal diseases and increasing developments of biologics for gastrointestinal diseases. Strategic initiatives by gastrointestinal drugs market players are likely to offer opportunities for market growth. The gastrointestinal drugs market report emphasizes the key factors driving the market and showcases the developments of prominent players.

Gastrointestinal diseases are becoming prevalent worldwide. Many research institutes are offering funding to accelerate the discovery of new methods for the treatment of gastrointestinal disorders. For instance, Yale School of Medicine receives over US$ 8 million per year in research funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDKK). The primary research areas include understanding mechanisms responsible for pancreatic inflammation and pancreatitis genetics and immunobiology of inflammatory bowel disease, as well as complications and treatment of IBD, cirrhosis, viral hepatitis, and liver cancer. In addition, the UNC School of Medicine, which is engaged in the advancement of understanding the impacts of gastrointestinal and liver diseases and developing new treatments, accounted for a gastrointestinal research funding that exceeds US$ 20 million annually. The UNC Center for Functional Gastrointestinal and Motility Disorders has been a top global center for research on constipation, irritable bowel syndrome, and fecal incontinence. The research includes translational studies on the stool microbiome and genetic contributions to IBS, the development and validation of diagnostic criteria, clinical studies of the physiological and psychological mechanisms for symptoms, epidemiological studies, and systems-based research on healthcare delivery.

Apart from this, the American Gastroenterological Association Research Foundation provides approximately US$ 3 million in research grants yearly to investigators in the fields of gastroenterology and hepatology. In June 2023, the American Gastroenterological Association and American College of Gastroenterology invested in Oshi Health to accelerate the adoption of hybrid digestive healthcare. Oshi Health provides diagnosis and integrated care for digestive conditions. By funding various researchers, the foundation is also supporting the discovery of new tools and treatments for people suffering from digestive problems.

Gastrointestinal clinical research has evolved over the past decade. The use of Artificial intelligence (AI) is becoming increasingly common in many areas, particularly in the medical field. AI has the potential to revolutionize the design of gastrointestinal clinical research. The integration of AI algorithms enables researchers to extract essential insights from enormous patient data sets, resulting in more accurate and personalized treatments for gastrointestinal conditions. Further, machine learning algorithms help analyze patient data, genetic profiles, and treatment outcomes to find predictive markers for therapy response. By precisely identifying patient subgroups that are most likely to benefit from particular interventions, researchers can optimize treatment strategies and enhance patient outcomes.

AI-powered image analysis has the potential to transform the field of diagnostic imaging in gastrointestinal medicine. Researchers can examine medical images, such as CT scans or endoscopic images, to detect and classify abnormalities with high accuracy by using deep learning algorithms. This technology facilitates the early detection and characterization of gastrointestinal lesions, enabling timely interventions and improving patient prognosis. For example, studies have shown the efficacy of AI algorithms in diagnosing and characterizing colorectal polyps during colonoscopy, reducing the need for unnecessary surgeries. With a US$ 98,700 grant from the Newcastle Permanent Charitable Foundation on research, researchers are able to utilize AI to develop new therapies for IBD and ulcerative colitis. The microbiome and intestinal stem cells are two key components that are significant drivers of IBD but are not targeted by current therapies. identifying therapies from the gut microbiome is a complex undertaking with vast amounts of data, which is why applying AI in such research helps a lot, as it can recognize patterns in enormous amounts of data. AI also enhances the quality of not only the diagnostic process but also of individualized therapeutic strategies.

Based on type, the gastrointestinal drugs market is segmented into biologics, antidiarrheal and laxatives, acid neutralizers, anti-inflammatory drugs, antiemetic and antinauseants, and others. The biologics segment held a larger gastrointestinal drugs market share in 2023; however, the antidiarrheal and laxatives segment is expected to register a higher CAGR during 2023–2031.

Based on Application, the market is segmented into irritable bowel syndrome, inflammatory ulcerative colitis, Crohn’s disease, gastroenteritis, celiac disease, and others. The irritable bowel syndrome segment held the largest gastrointestinal drugs market share in 2023, and gastroenteritis segment is estimated to register the highest CAGR during 2023–2031. Gastroenteritis or stomach flu is the irritation and inflammation of the digestive tract caused by a viral, bacterial, or parasitic infection with symptoms such as diarrhea, vomiting, nausea, and abdominal pain. The most common cause of viral gastroenteritis is norovirus and rotavirus. According to the Centers for Disease Control and Prevention (CDC), as of 2024, norovirus caused approximately 685 million cases of acute gastroenteritis worldwide, making it the most common cause of acute gastroenteritis. According to the same source, 200 million cases are diagnosed among children under 5 years of age, leading to an estimated 50,000 child deaths every year, mostly in developing countries. Further, every year, norovirus treatment is estimated to cost US$ 60 billion globally.

Sanofi SA, GSK Plc, Johnson & Johnson, Bausch Health Companies Inc, AstraZeneca Plc, Takeda Pharmaceutical Co Ltd, AbbVie Inc, Bayer AG, Celltrion Inc, and Pfizer Inc. are among the leading companies operating in the global gastrointestinal drugs market.

Companies operating in the gastrointestinal drugs market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the gastrointestinal drugs market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall gastrointestinal drugs market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the gastrointestinal drugs market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the gastrointestinal drugs market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Gastrointestinal Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Gastrointestinal Drugs Market – Key Market Dynamics
5.1 Gastrointestinal Drugs Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Cases of Gastrointestinal Diseases
5.2.2 Increasing Development of Biologics
5.3 Market Restraints
5.3.1 High Cost of Biologics
5.3.2 Average Cost of Biologic Drugs for Severe Ulcerative Colitis or Crohn’s Disease
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Increasing Research Investment for Novel Drug Development and Artificial Intelligence-Based Techniques
5.6 Impact of Drivers and Restraints:
6. Gastrointestinal Drugs Market – Global Market Analysis
6.1 Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031
6.2 Gastrointestinal Drugs Market Forecast Analysis
7. Gastrointestinal Drugs Market Analysis – by Drug Class
7.1 Biologics
7.1.1 Overview
7.1.2 Biologics: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Antidiarrheal and Laxatives
7.2.1 Overview
7.2.2 Antidiarrheal and Laxatives: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 Acid Neutralizers: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Anti-inflammatory Drugs
7.4.1 Overview
7.4.2 Anti-inflammatory Drugs: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Antiemetic and Antinauseants
7.5.1 Overview
7.5.2 Antiemetic and Antinauseants: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8. Gastrointestinal Drugs Market Analysis – by Application
8.1 Irritable Bowel Syndrome
8.1.1 Overview
8.1.2 Irritable Bowel Syndrome: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Inflammatory Ulcerative Colitis
8.2.1 Overview
8.2.2 Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Crohns Disease
8.3.1 Overview
8.3.2 Crohns Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Gastroenteritis
8.4.1 Overview
8.4.2 Gastroenteritis: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Celiac Disease
8.5.1 Overview
8.5.2 Celiac Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
9. Gastrointestinal Drugs Market Analysis – by Route Of Administration
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Parenteral
9.2.1 Overview
9.2.2 Parenteral: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10. Gastrointestinal Drugs Market Analysis – by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Online Pharmacies
10.3.1 Overview
10.3.2 Online Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11. Gastrointestinal Drugs Market – Geographical Analysis
11.1 North America
11.1.1 North America Gastrointestinal Drugs Market Overview
11.1.2 North America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.1.2.1 North America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Drug Class
11.1.2.2 North America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Application
11.1.2.3 North America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
11.1.2.4 North America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
11.1.3 North America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
11.1.3.1 United States: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.1.3.1.1 United States: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.1.3.1.2 United States: Gastrointestinal Drugs Market Breakdown, by Application
11.1.3.1.3 United States: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.1.3.1.4 United States: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.1.3.2 Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.1.3.2.1 Canada: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.1.3.2.2 Canada: Gastrointestinal Drugs Market Breakdown, by Application
11.1.3.2.3 Canada: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.1.3.2.4 Canada: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.1.3.3 Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.1.3.3.1 Mexico: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.1.3.3.2 Mexico: Gastrointestinal Drugs Market Breakdown, by Application
11.1.3.3.3 Mexico: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.1.3.3.4 Mexico: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2 Europe
11.2.1 Europe Gastrointestinal Drugs Market Overview
11.2.2 Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2.2.1 Europe: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Drug Class
11.2.2.2 Europe: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Application
11.2.2.3 Europe: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
11.2.2.4 Europe: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.3 Europe: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
11.2.3.1 Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.1.1 Germany: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.1.2 Germany: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.1.3 Germany: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.1.4 Germany: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.2 United Kingdom: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.2.1 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.2.2 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.2.3 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.2.4 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.3 France: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.3.1 France: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.3.2 France: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.3.3 France: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.3.4 France: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.4 Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.4.1 Italy: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.4.2 Italy: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.4.3 Italy: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.4.4 Italy: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.5 Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.5.1 Spain: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.5.2 Spain: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.5.3 Spain: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.5.4 Spain: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.6 Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.6.1 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.6.2 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.6.3 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.6.4 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3 Asia Pacific
11.3.1 Asia Pacific Gastrointestinal Drugs Market Overview
11.3.2 Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.3.2.1 Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Drug Class
11.3.2.2 Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Application
11.3.2.3 Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
11.3.2.4 Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.3 Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
11.3.3.1 China: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.1 China: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.1.2 China: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.1.3 China: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.1.4 China: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.2 Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 Japan: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.2.2 Japan: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.2.3 Japan: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.2.4 Japan: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.3 India: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 India: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.3.2 India: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.3.3 India: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.3.4 India: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.4 Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 Australia: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.4.2 Australia: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.4.3 Australia: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.4.4 Australia: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.5 South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 South Korea: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.5.2 South Korea: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.5.3 South Korea: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.5.4 South Korea: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.6 Rest of APAC: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.6.2 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.6.3 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.6.4 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4 Middle East & Africa
11.4.1 Middle East & Africa Gastrointestinal Drugs Market Overview
11.4.2 Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.4.2.1 Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Drug Class
11.4.2.2 Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Application
11.4.2.3 Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
11.4.2.4 Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.1.1 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.1.2 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.1.3 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.1.4 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4.3.2 South Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.2.1 South Africa: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.2.2 South Africa: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.2.3 South Africa: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.2.4 South Africa: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4.3.3 United Arab Emirates: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.3.1 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.3.2 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.3.3 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.3.4 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4.3.4 Rest of Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.4.1 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.4.2 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.4.3 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.4.4 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.5 South & Central America
11.5.1 South & Central America Gastrointestinal Drugs Market Overview
11.5.2 South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.5.2.1 South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Drug Class
11.5.2.2 South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Application
11.5.2.3 South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
11.5.2.4 South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.3 South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
11.5.3.1 Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.1.1 Brazil: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.5.3.1.2 Brazil: Gastrointestinal Drugs Market Breakdown, by Application
11.5.3.1.3 Brazil: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.5.3.1.4 Brazil: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.5.3.2 Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.2.1 Argentina: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.5.3.2.2 Argentina: Gastrointestinal Drugs Market Breakdown, by Application
11.5.3.2.3 Argentina: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.5.3.2.4 Argentina: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.5.3.3 Rest of South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.3.1 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.5.3.3.2 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Application
11.5.3.3.3 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.5.3.3.4 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Gastrointestinal Drugs Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Sanofi SA
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GSK Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson & Johnson
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AstraZeneca Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Takeda Pharmaceutical Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 AbbVie Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bayer AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Celltrion Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Pfizer Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Gastrointestinal Drugs Market Segmentation
Table 2. North America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 3. North America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 4. North America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 5. North America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 6. United States: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 7. United States: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 8. United States: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 9. United States: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 10. Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 11. Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 12. Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 13. Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 14. Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 15. Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 16. Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 17. Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 18. Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 19. Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 20. Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 21. Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 22. Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 23. Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 24. Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 25. Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 26. United Kingdom: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 27. United Kingdom: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 28. United Kingdom: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 29. United Kingdom: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 30. France: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 31. France: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 32. France: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 33. France: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 34. Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 35. Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 36. Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 37. Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 38. Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 39. Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 41. Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 42. Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 43. Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 44. Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 45. Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 46. Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 47. Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 48. Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 49. Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 50. China: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 51. China: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 52. China: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 53. China: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 54. Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 55. Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 56. Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 57. Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 58. India: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 59. India: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 60. India: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 61. India: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 62. Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 63. Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 64. Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 65. Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 66. South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 67. South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 68. South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 69. South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 70. Rest of APAC: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 71. Rest of APAC: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 72. Rest of APAC: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 73. Rest of APAC: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 74. Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 75. Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 76. Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 77. Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 78. Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 79. Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 80. Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 81. Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 82. South Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 83. South Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 84. South Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 85. South Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 86. United Arab Emirates: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 87. United Arab Emirates: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 88. United Arab Emirates: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 89. United Arab Emirates: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 90. Rest of Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 91. Rest of Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 92. Rest of Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 93. Rest of Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 94. South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 95. South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 96. South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 97. South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 98. Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 99. Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 100. Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 101. Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 102. Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 103. Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 104. Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 105. Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 106. Rest of South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 107. Rest of South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 108. Rest of South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration
Table 109. Rest of South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 110. Recent Organic Growth Strategies in Gastrointestinal Drugs Market
Table 111. Recent Inorganic Growth Strategies in the Gastrointestinal Drugs Market
Table 112. Glossary of Terms, Gastrointestinal Drugs Market

LIST OF FIGURES

Figure 1. Gastrointestinal Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031
Figure 5. Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 6. Gastrointestinal Drugs Market Share (%) – by Drug Class (2023 and 2031)
Figure 7. Biologics: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Antidiarrheal and Laxatives: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Acid Neutralizers: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Anti-inflammatory Drugs: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Antiemetic and Antinauseants: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Gastrointestinal Drugs Market Share (%) – by Application (2023 and 2031)
Figure 14. Irritable Bowel Syndrome: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Crohns Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Gastroenteritis: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Celiac Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Gastrointestinal Drugs Market Share (%) – by Route Of Administration (2023 and 2031)
Figure 21. Oral: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Parenteral: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Gastrointestinal Drugs Market Share (%) – by Distribution Channel (2023 and 2031)
Figure 24. Hospital Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Retail Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Online Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. North America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. North America: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 29. United States: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. United Kingdom: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. France: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Asia Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Asia Pacific: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. China: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. India: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Rest of APAC: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 50. Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. South Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. United Arab Emirates: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. Rest of Middle East & Africa: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. South & Central America: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 56. Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Rest of South & Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Growth Strategies in Gastrointestinal Drugs Market